Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Phase 3 Malaria Trials

8 Phase 3 trials for Malaria. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.

What is a Phase 3 trial?

Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
RECRUITINGPhase 3NCT06962319

Safety of Antimalarials in the FIRst trimEster

The SAFIRE study aims to find effective treatments with acceptable safety for malaria in early pregnancy, a particularly sensitive time for the adverse consequences of malaria in...

Sponsor: Liverpool School of Tropical MedicineEnrolling: 15103 locations
RECRUITINGPhase 3NCT06148792

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

The goal of this clinical trial is to assess the efficacy and safety or a revised weight band tafenoquine dose in vivax malaria patients. The main question\[s\] it aims to answer...

Sponsor: Menzies School of Health ResearchEnrolling: 10904 locations
RECRUITINGPhase 3NCT06923592

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

The resilience of P. vivax to malaria elimination efforts is due to its ability to form dormant liver stages (hypnozoites) that reactivate weeks to months after the initial...

Sponsor: London School of Hygiene and Tropical MedicineEnrolling: 192002 locations
RECRUITINGPhase 3NCT05951595

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and...

The goal of this open-label randomised, controlled, non-inferiority trial is to assess and compare the efficacy, tolerability and safety of a fixed dose TACT...

Sponsor: University of OxfordEnrolling: 16801 location
RECRUITINGPhase 3NCT06578572

Seasonal R21 Mass Vaccination for Malaria Elimination

This is a cluster randomized trial to determine the impact of seasonal R21/MM mass vaccination (all ages) on malaria transmission and morbidity. Fifty-four villages (30 in The...

Sponsor: London School of Hygiene and Tropical MedicineEnrolling: 162002 locations
RECRUITINGPhase 3NCT07082205

Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge

Background and rationale: Hospitalised children with severe anaemia remain at high risk of dying or requiring hospital readmission for at least 6 months after discharge. In highly...

Sponsor: Liverpool School of Tropical MedicineEnrolling: 3982 locations
RECRUITINGPhase 3NCT05690841

FocaL Mass Drug Administration for Vivax Malaria Elimination

FLAME is an open-label cluster-randomized controlled trial that aims to determine the effectiveness of focal mass drug administration (fMDA) to reduce the incidence of Plasmodium...

Sponsor: University of California, San FranciscoEnrolling: 75301 location
RECRUITINGPhase 3NCT06666491

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are...

The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.

Sponsor: GlaxoSmithKlineEnrolling: 3004 locations